These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 5975310)

  • 1. [Symposium on the open negative syndrome. 9. Summary of answers to inquiries on indications for the treatment of open negative cases].
    Iwasaki T
    Kekkaku; 1966 Aug; 41(8):392. PubMed ID: 5975310
    [No Abstract]   [Full Text] [Related]  

  • 2. [Symposium on the open negative syndrome. 2. Formation of the open negative cavity during the course of original treatment and the fate of the cavity].
    Miyagi Y
    Kekkaku; 1966 Aug; 41(8):375-8. PubMed ID: 5975303
    [No Abstract]   [Full Text] [Related]  

  • 3. [Symposium on the open negative syndrome. 5. Studies on the open negative syndrome occurring after chemotherapy with secondary antituberculous drugs].
    Kimura Y
    Kekkaku; 1966 Aug; 41(8):383-6. PubMed ID: 5975306
    [No Abstract]   [Full Text] [Related]  

  • 4. [Symposium on open negative syndrome. 10. Summary].
    Iwasaki T
    Kekkaku; 1966 Aug; 41(8):392-4. PubMed ID: 5975311
    [No Abstract]   [Full Text] [Related]  

  • 5. "Open-negative" syndrome. Clinical course of its development and subsequent destiny.
    Miyagi Y
    Jpn J Tuberc; 1966 Dec; 13():Suppl:54-9. PubMed ID: 5298479
    [No Abstract]   [Full Text] [Related]  

  • 6. [Symposium on the open negative syndrome. 8. Problems of the open negative syndrome].
    Hamano S
    Kekkaku; 1966 Aug; 41(8):390-2. PubMed ID: 5975309
    [No Abstract]   [Full Text] [Related]  

  • 7. [Symposium on the open negative syndrome. 3. Pathological and bacteriological study of the open negative cavity].
    Iwai K
    Kekkaku; 1966 Aug; 41(8):378-80. PubMed ID: 5975304
    [No Abstract]   [Full Text] [Related]  

  • 8. Summary of answers on inquiry of indication of treatment of 4 open negative cases.
    Iwasaki T
    Jpn J Tuberc; 1966 Dec; 13():Suppl:90. PubMed ID: 5298486
    [No Abstract]   [Full Text] [Related]  

  • 9. [Symposium on the open negative syndrome. 4. Study on the prognosis of the open negative syndrome occurring after chemotherapy with primary anti-tuberculous drugs].
    Fujioka M; Yoshida F; Komoto H; Takahashi O; Nishiyama K
    Kekkaku; 1966 Aug; 41(8):381-3. PubMed ID: 5975305
    [No Abstract]   [Full Text] [Related]  

  • 10. [Symposium on the open negative syndrome. 7. Prognosis of open negative cases under work].
    Takahara T
    Kekkaku; 1966 Aug; 41(8):388-90. PubMed ID: 5975308
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathological and bacteriological study of open negative cavity.
    Iwai K
    Jpn J Tuberc; 1966 Dec; 13():Suppl:59-64. PubMed ID: 5298480
    [No Abstract]   [Full Text] [Related]  

  • 12. [Follow-up observation on open negative cases].
    Taga M; Yamamoto M; Hirose H; Katayama A; Matsumoto M
    Kekkaku; 1967 Jan; 42(1):9-14. PubMed ID: 6036571
    [No Abstract]   [Full Text] [Related]  

  • 13. [Symposium on the open negative syndrome. 6. Studies on rehabilitation in tuberculous patients with open negative syndrome].
    Yamaki I
    Kekkaku; 1966 Aug; 41(8):386-8. PubMed ID: 5975307
    [No Abstract]   [Full Text] [Related]  

  • 14. [Lung resection in tubercle bacteria-negative residual openings (open negative syndrome)].
    Voigt H; Landmann H; Krüger A; Walter M; Wihelm J
    Z Tuberk Erkr Thoraxorg; 1967 Apr; 126(1):28-35. PubMed ID: 5631775
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bacteriological and histo-pathological studies of the resected "open-negative cavities" and a clinical trial to shorten the duration of chemotherapy].
    Takahashi T
    Kekkaku; 1972 Dec; 47(12):491. PubMed ID: 4631480
    [No Abstract]   [Full Text] [Related]  

  • 16. [Extension of indications for cavernotomy in patients with pulmonary tuberculosis].
    Saburenkova EP; Koleshko LE
    Klin Med (Mosk); 1966 Dec; 44(12):43-7. PubMed ID: 6004340
    [No Abstract]   [Full Text] [Related]  

  • 17. [Symposium: negative tuberculous cavity].
    Shiozawa M; Suganuma A; Kawame S; Hatanaka E; Sato M
    Kekkaku; 1970 Sep; 45(9):312-3. PubMed ID: 5460511
    [No Abstract]   [Full Text] [Related]  

  • 18. [Present condition of patients discharged in 1963 and 1964 with negative sputum and open cavern].
    Sutalo I
    Tuberkuloza; 1966; 18(6):542-9. PubMed ID: 16296040
    [No Abstract]   [Full Text] [Related]  

  • 19. [The first-three year report of the Tuberculosis Control Project, Lumbini, Rupandehi].
    Masuyama H; Takase A; Aoki M; Shimao T
    Kekkaku; 1998 Dec; 73(12):697-703. PubMed ID: 10028803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A controlled trial of 6-month and 12-month regimens after negative conversion of sputum in the original treatment of pulmonary tuberculosis. Report of the 21st series of controlled trials of chemotherapy. Cooperative Study Unit of Chemotherapy of Tuberculosis of National Sanatoria in Japan (CSUCTNS)].
    Kekkaku; 1984 Feb; 59(2):81-9. PubMed ID: 6379258
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.